CNIC Events mobile

Click here to register!

We look forward to hearing from NUCM Radiopharma, Agescan International, Novartis, Mirion, and Rayatom Technologies for this exciting webinar!

Click here to register for this web event sponsored by the Canadian Medical Isotope Ecosystem.

Due to the transformative potential of nuclear medicine for the diagnosis and treatment of illnesses like cancer, the isotope industry is beginning to position itself as the next major investment trend. As the global market for nuclear medicine is expected to grow to nearly $33 billion US in the next decade, there is a significant lucrative outlook for those who capitalize on this emerging opportunity.

This event will feature leaders in the investment community who will draw from their experience to outline opportunities for the industry to better engage with investors, including elements of successful pitch presentations. A panel of speakers will discuss topics like their approach to financial forecasting and predicting industry trends, challenges to attracting investment, and how industry can build more intentional relationships with the investment community to help meet project needs.

Join us as we explore how the medical isotope industry in Canada is poised for growth, offering rewarding prospects across the supply chain.